In HCT116 xenograft mice, compared with in the control group, an increasing trend in ROS production was observed in NCI-006- and IACS-010759-treated groups, and a significant increase was observed in the combination-treated group (p < 0.05, Fig 3B ).
← all excerpts
Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch.
1
—
—